# Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions

**In short:** The guidance sets out FDA's recommendations on cybersecurity in device design and labeling and on the cybersecurity documentation to include in premarket submissions, and covers its recommendations under section 524B for cyber devices, including the software bill of materials. It treats cybersecurity as part of device safety and of the Quality Management System Regulation, and describes a secure product development framework as one way to satisfy that regulation. The February 3, 2026 version supersedes the June 27, 2025 version and aligns the text with the amended 21 CFR part 820, which took effect on February 2, 2026.

FDA guidance, Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (February 3, 2026; docket FDA-2021-D-1158) · Healthcare · Security & Resilience. Published November 14, 2026. Last reviewed November 14, 2026.

## At a glance

- Citation: FDA guidance, Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (February 3, 2026; docket FDA-2021-D-1158)
- Issued by: Food and Drug Administration
- Type: Guidance
- Status: Effective (as of November 14, 2026) [2] This is final guidance. It states that FDA guidance does not establish legally enforceable responsibilities and that its recommendations are not required unless specific regulatory or statutory requirements are cited. [1]
- Applies to: Devices with cybersecurity considerations, including devices with a device software function or that contain software, firmware or programmable logic, whether or not they are network-enabled; premarket submissions to CDRH or CBER (510(k), De Novo, PMA and PMA supplements, PDP, IDE, HDE, BLA and IND); devices that need no premarket submission; and cyber devices under section 524B.
- Jurisdiction: United States (federal)

## Key dates

Each date ends with the number of its source in "Sources". Dates were checked on November 14, 2026 unless the row gives another date.

| Date | Kind | What | Source |
|---|---|---|---|
| September 27, 2023 | Published | First version of the final guidance issued | [3] |
| June 27, 2025 | Phase begins | Revised guidance adds Section VII on section 524B and cyber devices | [3] |
| February 3, 2026 | Published | Current version issued, superseding the June 27, 2025 version. FDA's Medical Device Cybersecurity page lists this version under February 2, 2026; the guidance document says it was issued on February 3, 2026, and its guidance page dates it February 2026. | [1] |

## What it changed

FDA first issued this final guidance on September 27, 2023. The June 27, 2025 version added Section VII on section 524B and cyber devices, and the February 2026 version revised the guidance to align with the Quality Management System Regulation, which incorporates ISO 13485:2016 by reference.

## Sources

1. U.S. Food and Drug Administration. Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (guidance document, February 3, 2026). <https://www.fda.gov/media/119933/download> Checked November 14, 2026.
2. U.S. Food and Drug Administration. Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions (guidance page). <https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cybersecurity-medical-devices-quality-management-system-considerations-and-content-premarket> Checked November 14, 2026.
3. U.S. Food and Drug Administration. Medical Device Cybersecurity (resources and updates). <https://www.fda.gov/medical-devices/medical-device-cybersecurity> Checked November 14, 2026.

Last reviewed: November 14, 2026
Canonical URL: <https://insights.moraph.com/rules/fda-premarket-cybersecurity-guidance-2026>
Publisher: Moraph Insights
